JPS59170015A - Treatment of animal plasma - Google Patents

Treatment of animal plasma

Info

Publication number
JPS59170015A
JPS59170015A JP58042240A JP4224083A JPS59170015A JP S59170015 A JPS59170015 A JP S59170015A JP 58042240 A JP58042240 A JP 58042240A JP 4224083 A JP4224083 A JP 4224083A JP S59170015 A JPS59170015 A JP S59170015A
Authority
JP
Japan
Prior art keywords
plasma
solution
globulin
albumin
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58042240A
Other languages
Japanese (ja)
Inventor
Shiro Watanabe
渡辺 史朗
Kenichi Okada
憲一 岡田
Masanori Kishi
岸 正則
Tadayoshi Endo
遠藤 忠良
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Priority to JP58042240A priority Critical patent/JPS59170015A/en
Publication of JPS59170015A publication Critical patent/JPS59170015A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE:To obtain globulin and albumin useful a raw material for foods, feeds, drugs, etc. simply and economically, by adding a Ca solution to animal plasma so that it is adjusted to a specific pH, fractionating precipitated fibrinogen effectively. CONSTITUTION:A plasma fraction is collected from blood of animal such as swine, bovine, etc. by a common separation method, an aqueous solution of a Ca salt or calcium hydroxide is added to the plasma, and the solution is adjusted to 6-10 pH, preferably 7-9 pH, so that precipitated fibrinogen is agglomerated and fractionated effectively, to collect plasma protein of globulin and albumin. An amount of the Ca solution added is properly 0.02-0.08 molar concentration based on plasma. This method is different from conventional ammonium sulfate method, sodium sulfate method, ethanol fractionation method, heavy metal salt method, etc., and it is simple and economically advantageous.

Description

【発明の詳細な説明】 本発明は、動物の血液を遠心分離もしくは膜分離して得
られる血漿からグロブリンおよびアルブミン等の主要血
漿蛋白質を得るに際し、血液凝固の中心的役割金なすフ
ィブリノーゲンを効果的に凝集分別する方法に関する。
Detailed Description of the Invention The present invention effectively eliminates fibrinogen, which plays a central role in blood coagulation, when obtaining major plasma proteins such as globulin and albumin from plasma obtained by centrifugation or membrane separation of animal blood. This invention relates to a method for agglomeration separation.

動物血液は、わが国においては、ごく一部血漿画分が動
物薬および食品用に利用されているか、あるいは乾燥血
粉として肥料、飼料原料に利用されているが、大部分は
有効に利用されていない現状である。
In Japan, a small portion of animal blood is used as plasma fraction for animal medicine and food, or as dried blood meal for fertilizer and feed materials, but the majority is not used effectively. This is the current situation.

本発明者らは、かかる未利用血液から広い用途が期待さ
れている血漿蛋白質、特にグロブリンおよびアルブミン
の含有量の高い蛋白質を得る方法に関して、棟々研死を
行なった結果、文献上知られている硫安法、硫酸ソーダ
法、エタノール分別沈殿法、リン酸塩法、重金縞塩法な
どとは異なる簡便かつ経洒的有利な方法を見出した。
The present inventors have conducted extensive research into methods for obtaining plasma proteins, which are expected to have a wide range of uses, from such unused blood, particularly proteins with high globulin and albumin content. We have discovered a simple and economically advantageous method that is different from the ammonium sulfate method, sodium sulfate method, ethanol fractional precipitation method, phosphate method, and heavy metal salt method.

すなわち、豚、牛等の動物屠体から内接採取した血液に
、フィブリノーゲンのゲル化防止剤としてクエン酸ソー
ダを添加した後、3111常の遠心分離法もしくは血漿
分離用膜による分離法にて血漿画分を集め、これにカル
シウム塩もしくは水酸化カルシウムの水浴液金混せし、
溶液のpH’に6〜10、好ましくは7〜9の範囲に調
整して、析出するフィブリノーゲン會分別することによ
り、オリ用価値の高いグロブリンおよびアルブミンの血
漿蛋白質全容易に採取する方法である。
That is, after adding sodium citrate as an agent to prevent gelation of fibrinogen to the blood collected internally from the carcass of an animal such as a pig or cow, plasma is separated by a conventional centrifugation method or a separation method using a plasma separation membrane. Collect the fractions, mix with calcium salt or calcium hydroxide water bath liquid gold,
By adjusting the pH of the solution to a range of 6 to 10, preferably 7 to 9, and separating the precipitated fibrinogen, all plasma proteins such as globulin and albumin, which have high utility value, can be easily collected.

このようなグロブリン、アルブミン等の血漿蛋白質の採
取法の利点は、従来法における塩析法のごとく、硫安な
いし硫酸ソーダ全多量に要したり、分画蛋白質に多量の
無機塩が混入する問題や、アルコール沈殿法のごとく、
溶剤回収の問題等がないこと、さらには有毒な重金属類
全使用しないことなど金挙げることができる。
The advantage of this method of collecting plasma proteins such as globulin and albumin is that, unlike the conventional salting-out method, it does not require a large amount of ammonium sulfate or sodium sulfate, and it does not have problems such as large amounts of inorganic salts contaminating the fractionated proteins. , like the alcohol precipitation method,
There are no problems with solvent recovery, and no toxic heavy metals are used.

本発明方法をさらに詳記すると、壕ず、動物屠体から採
血され、常法により血球成分を除いた血漿画分にカルシ
ウム溶液全添加するが、その硲加量は、通常蛋白實とし
て7〜9%営む血漿に対し0.01〜D、1 モル(I
IJ(〕範囲に、殊に0.02〜0.088モル濃が適
当で、上記範囲外では、ケル化現象が生じ好ましくない
。かかるカルンウム塩硲加によるフィブリノ−ケンの1
テ「出には、溶τ夜の17Hを6〜10、好捷しくは7
〜9の範囲に肌i整することが重要であり、上記範囲全
逸脱すると目的全達成することができない。さらに、フ
ィブリノーゲンの析出および溶液からの分hv を容易
ならしのるため、必要に応じて血漿に水を加えることが
できる。引出したフィブリノ−ケン画分は、通常f−■
なわれる濾過法または遠心分離法にて容易に分かくして
得らノするグロブリンおよびアルブミンの画工白質を含
む画分ば、その−f\斗たは必要に応じて脱塩、精製し
、食品、N相、医薬品原料などとして重要な用途があり
、他方、フィブリノ−ケン曲1分につめても、食品添加
物、医桑品原:i’:;I々どとして新しい用途がル」
待されている。
To describe the method of the present invention in more detail, blood is collected from an animal carcass in a trench, and the entire calcium solution is added to the plasma fraction from which blood cell components have been removed by a conventional method. 0.01-D, 1 mol (I
IJ() range, particularly 0.02 to 0.088 molar concentration, is suitable; outside the above range, a kelization phenomenon occurs, which is undesirable.
``To get out, set 17H at night to 6-10, preferably 7.
It is important to keep the temperature within the range of 9 to 9, and if you deviate from the above range, you will not be able to achieve the full purpose. In addition, water can be added to the plasma as needed to facilitate the precipitation of fibrinogen and its removal from solution. The drawn fibrinokene fraction is usually f-■
Fractions containing white matter such as globulin and albumin, which can be easily separated by conventional filtration or centrifugation, can be desalted and purified as necessary to produce food, nitrogen, etc. On the other hand, fibrinogen, which can be compressed into one minute, has new uses such as food additives and medical products.
Waiting.

次に実施例を挙げ、本発明全具体的に説明する。Next, the present invention will be explained in detail with reference to Examples.

実施例1 濡場にて成ノ体層体がら得た所鮮血液杓11に素早く1
0%クエン酸ソーダ浴液30meを添加した後、水冷下
に遠心分離を行い、血漿、i!:) 0.55 l奮得
た。この血漿500 mlに、10裂塩化力ルンウム(
2水塩)溶jW 30 mbよ(J水15 G mlf
それぞれ加え(血漿に対するカル7ウム塩id 約o、
 04モル濃度)、溶液のpH全8.2として室温で約
6゜分1−」撹拌することにより、フィブリノーゲン全
析出させた。次に、これkP別し、フィブリノ−クン画
分47゜59(水分約9o%)、グロブリ/およびアル
ブミン画分約650m1fそれぞれ採取した。ナオ、後
者の血漿蛋白質グロブリンとアルブミンの含有割合は、
ゲル電気泳動法にて測定した結果、略7:10であり、
フィブリノーゲンは殆んど含まれていなかった。
Example 1 Quickly add 1 scoop of fresh blood obtained from the adult body layer in a wet field.
After adding 30me of 0% sodium citrate bath solution, centrifugation was performed under water cooling, plasma, i! :) I gained 0.55 l. To 500 ml of this plasma, add 10-fiber chloride (
dihydrate salt) dissolved JW 30 mb (J water 15 G mlf
Added (calcium salt id to plasma approximately o,
Fibrinogen was completely precipitated by stirring at room temperature for about 6 minutes at a pH of 8.2 (total pH 8.2). Next, this was separated by kP, and a fibrinokun fraction of 47.59 mm (water content approximately 90%) and a globulin/albumin fraction of approximately 650 m1f were collected. Nao, the content ratio of plasma protein globulin and albumin in the latter is
As a result of measurement by gel electrophoresis, it was approximately 7:10,
Almost no fibrinogen was included.

実施例2 層楊にて牛から採取した新鮮血液約2tに素早く10%
クエン酸ソーダ溶液50 ml全添加した後、水冷し、
遠心分離によジ上清部の血漿画分約1.o5tk得た。
Example 2 Quickly add 10% to approximately 2 tons of fresh blood collected from a cow in Laiyang
After adding all 50 ml of sodium citrate solution, cool with water,
By centrifugation, the plasma fraction of the disupernatant was separated by approximately 1. I got o5tk.

かかる血漿1tを採取し、水1tおよび5チ水酸化力ル
シウム溶液25m1をそれぞれ添加した後、′塩酸にて
pH8,8に調整し、攪拌後、需/&4〜8℃にて1夜
放置後、析出したフィブリノーゲンを沢別して、透明な
グロブリンおよびアルブミン全含有する蛋白質画分の浴
液約1.9を全倚た。かかる蛋白質画分をケル電気隊i
#J法にて分析したところ、フィブリノ−クンは殆んと
検出されなかった。
Collect 1 t of plasma, add 1 t of water and 25 ml of 5% lucium hydroxide solution, adjust the pH to 8.8 with hydrochloric acid, stir, and leave overnight at 4-8°C. The precipitated fibrinogen was thoroughly separated, and about 1.9 g of the protein fraction bath solution containing all of the transparent globulin and albumin was swallowed. Such protein fraction was
When analyzed by the #J method, almost no fibrinokun was detected.

Claims (1)

【特許請求の範囲】[Claims] 動物の血液から得られる血漿にカルシウム塩もしくは水
酸化カルシウムの水溶液を添加し、溶液のr)H’k 
6ないし10の範囲に調整することによジ、析出するフ
ィブリノ−ケンを分別してグロブリンおよびアルブミン
の血漿蛋白質全取得するとと會%徴とする動物血漿の処
理法。
An aqueous solution of calcium salt or calcium hydroxide is added to plasma obtained from animal blood, and the r)H'k of the solution is
A method for treating animal plasma in which the precipitated fibrinokene is fractionated and all plasma proteins such as globulin and albumin are obtained by adjusting the concentration within the range of 6 to 10.
JP58042240A 1983-03-16 1983-03-16 Treatment of animal plasma Pending JPS59170015A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP58042240A JPS59170015A (en) 1983-03-16 1983-03-16 Treatment of animal plasma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58042240A JPS59170015A (en) 1983-03-16 1983-03-16 Treatment of animal plasma

Publications (1)

Publication Number Publication Date
JPS59170015A true JPS59170015A (en) 1984-09-26

Family

ID=12630500

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58042240A Pending JPS59170015A (en) 1983-03-16 1983-03-16 Treatment of animal plasma

Country Status (1)

Country Link
JP (1) JPS59170015A (en)

Similar Documents

Publication Publication Date Title
Westall Argininosuccinic aciduria: identification and reactions of the abnormal metabolite in a newly described form of mental disease, with some preliminary metabolic studies
US5455331A (en) Enriched whey protein fractions and method for the production thereof
EP0023607B1 (en) Process for preparing a collagen solution, such a solution and its use
JPH05500105A (en) Improved stable coagulation control
Dent et al. The Bence-Jones protein of multiple myelomatosis: its methionine content and its possible significance in relation to the aetiology of the disease
US4301064A (en) Ubiquitary tissue protein PP8
SE452250C (en) Methods to prepare a concentrate of prothrombin complex
Sellers et al. An electrophoretic study of urinary protein in the rat
JPS5910523A (en) Manufacture of blood coagulating factor viii:c
JPS59222420A (en) Manufacture of viii factor containing medicine
US2958628A (en) Heat treatable plasma protein product and method of preparation
JPH0381290A (en) Manufacture of refined albumin solution
JPH0822879B2 (en) Method for producing antihemophilic factor by cold precipitation and improving the solubility of the resulting antihemophilic factor product
Outhouse HUMAN MILK STUDIES. V. A QUANTITATIVE COMPARISON OF THE ANTIRICKETIC FACTOR IN HUMAN MILK AND COW'S MILK.* BY JULIA OUTHOUSE, ICIE G. MACY, AND VIOLA BREKKE.
JPS59170015A (en) Treatment of animal plasma
Dinning et al. Influence of vit. E deficiency in rabbit on urinary excretion of free amino acids.
JPS58124721A (en) Method of refining hormone of anterior lobe of pituitary
JPS6163247A (en) Production of globin protein
US3318771A (en) Process for the recovery of plasminogen from animal blood serum or animal blood plasma, preferably from pig's blood
SE443293B (en) Blood fraction FRONT TELL NING
US2369111A (en) Blood clotting accelerator
JPS63216898A (en) Collection of somatotropin from dilute aqueous solution
JP2824254B2 (en) Fibroblast growth substance
JPH05500205A (en) Hemin purification method, new hemin derivatives and their production method
Hilding et al. Amino Acid Composition of Human Nasal Mucus: Normal Subjects